Mizuho Issues Pessimistic Forecast for Ryan Specialty (NYSE:RYAN) Stock Price

Ryan Specialty (NYSE:RYAN) had its target price decreased by Mizuho from $53.00 to $44.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective suggests a potential upside of 11.97% from the stock’s previous close.

RYAN has been the topic of several other research reports. Weiss Ratings downgraded Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, February 5th. Zacks Research cut shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 24th. Morgan Stanley cut their price target on shares of Ryan Specialty from $61.00 to $55.00 and set an “overweight” rating on the stock in a report on Monday, February 23rd. UBS Group reduced their price target on shares of Ryan Specialty from $71.00 to $65.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Finally, The Goldman Sachs Group set a $61.00 price objective on shares of Ryan Specialty in a research note on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $56.87.

Ryan Specialty Price Performance

NYSE RYAN opened at $39.30 on Friday. Ryan Specialty has a 1 year low of $37.29 and a 1 year high of $77.16. The business’s fifty day moving average is $47.38 and its two-hundred day moving average is $52.62. The stock has a market capitalization of $10.38 billion, a P/E ratio of 93.56, a P/E/G ratio of 1.02 and a beta of 0.62. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The company had revenue of $751.21 million during the quarter, compared to analyst estimates of $777.43 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. The business’s revenue was up 13.2% compared to the same quarter last year. On average, research analysts forecast that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Timothy William Turner sold 129,570 shares of the company’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the transaction, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at approximately $672,966.33. This represents a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Patrick G. Ryan, Jr. acquired 25,500 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares of the company’s stock, valued at $17,114,668.20. This represents a 6.33% increase in their position. The disclosure for this purchase is available in the SEC filing. 52.21% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Ameritas Investment Partners Inc. raised its stake in shares of Ryan Specialty by 0.9% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock worth $1,190,000 after purchasing an additional 185 shares in the last quarter. MAI Capital Management increased its holdings in Ryan Specialty by 65.3% in the second quarter. MAI Capital Management now owns 476 shares of the company’s stock worth $32,000 after buying an additional 188 shares during the last quarter. Baker Tilly Wealth Management LLC raised its position in Ryan Specialty by 5.6% during the third quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock valued at $203,000 after acquiring an additional 192 shares in the last quarter. Public Employees Retirement System of Ohio lifted its stake in Ryan Specialty by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 32,797 shares of the company’s stock valued at $1,848,000 after acquiring an additional 203 shares during the last quarter. Finally, Covestor Ltd lifted its stake in Ryan Specialty by 16.8% in the fourth quarter. Covestor Ltd now owns 1,467 shares of the company’s stock valued at $76,000 after acquiring an additional 211 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.